Danaher Corporation acquired Pall Corporation for approximately $13.8 billion ($127.20 per share cash; total enterprise value including assumed debt and net of acquired cash), a transaction completed in August 2015, structured as all cash (merger).
Pall Corporation operates in Life Sciences (filtration), is based in Port Washington, New York, USA, had revenue of about $2.8 billion consolidated revenue in fiscal year ended July 2014 ($1.5 billion Life Sciences segment, $1.3 billion Industrial segment). Pall is a leading global provider of filtration, separation and purification solutions that remove contaminants or separate substances from a variety of solids, liquids and gases, serving the broad spectrum of life sciences and industry.
Pall is a highly attractive business, with approximately 75% recurring revenues, mid-single digit organic growth and a solid margin profile. Its best-in-class technology and broad, technically-advanced solutions make it the premier brand in the filtration industry, strengthening Danaher's life-sciences position in the high-growth biopharmaceutical market.
approximately 75% recurring revenues; biopharma exposure in the Life Sciences segment Danaher Life Sciences segment
Pall is a highly attractive business, with approximately 75% recurring revenues, mid-single digit organic growth and a solid margin profile. Pall will provide us a leading business with significant runway for expansion and strengthens our life sciences position in the strategically-attractive, high-growth biopharmaceutical market.Thomas P. Joyce, Jr., President and CEO, Danaher Corporation
Advisory firms were not disclosed for this transaction.